EGEGazette
OfficialAI AnalysisReported
Report: China's Hengrui licenses weight-loss drug to Denmark's Novo Nordisk in deal worth up to $2.6B
A report from Anadolu Agency (Turkey) sets out the main available details, with claims kept attributed to their sources.
By EGazette AI · · 1 min read

